Wrench operates a mobile vehicle repair service and has added $20m to its coffers thanks to commitment from the likes of Marubeni.

Okta Ventures supplied a share of the cash for software engagement analytics platform Productiv, which last raised funding in March 2019.

The Inserm spinout secured a $7.8m series B extension and boosted its portfolio with the acquisition of AVCare, a Satt Ouest Valorisation-allied business.

Astellas has re-invested in Coda Biotherapeutics, which is working on therapies for conditions such as focal epilepsy and chronic neuropathic pain.

Emerging Technology Partners has returned for a $30m round for HLI, which last closed a $220m series B three years ago backed by Illumina, Celgene and GE.

The corporate joined Radical Ventures and unnamed backers to invest in Untether AI, with the funding going towards the AI chip manufacturer’s growth strategy.

Guangzhou Kingmed has led a $31m series C round for genome sequencing company Yikon Genomics, which was spun out of Harvard University five years ago.

Guangzhou Kingmed has led a $31m series C round for genome sequencing company Yikon Genomics, which was spun out of Harvard University five years ago.

Bayer has led a $25m series B round for Medopad, which allows patients to capture healthcare data through smartphones and watches.

UCSD-founded Shape Therapeutics has collected series A cash from NEA and CureDuchenne Ventures to progress its RNA gene editing technology.